Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2013 Jul;62(1):26–40. doi: 10.1097/FJC.0b013e31828bc88a

Table 1.

EC50 for Phe contraction, ACh relaxation, and ER agonist-induced relaxation in cephalic, thoracic and abdominal arteries of female rat

Parameter Thoracic Aorta Carotid Pulmonary Abdominal Aorta Mesenteric Renal

pEC50 (−log M)
Phe Contraction
+ Endo 7.74±0.06 7.81±0.06 8.03±0.04*T,C 7.43±0.05*T,C,P 6.59±0.08*T,C,P,A 6.99±0.07*T,C,P,A,M
− Endo 8.14±0.08# 7.93±0.09 8.11±0.12 7.74±0.06# 6.33±0.14 7.07±0.14

pEC50 (−log M) Relaxation
of Phe Contraction
ACh
6.33±0.05 5.56±0.37 6.29±0.07 6.12±0.19 5.75±0.46 6.31±0.15
E2 6.72±1.10 2.55±0.38 *T 3.44±0.97 *T 5.39±0.59*C 4.08±0.56 *T,C 5.71±0.40*c,p,m
−Endo 2.03±0.20# 3.28±0.56 3.15±0.51 3.85±0.65 *T 4.91±0.69*t 4.51±0.45*t
PPT 6.86±0.89 3.65±0.62 *T 4.29±0.78 *T 6.06±0.60*C 5.46±1.08 5.96±0.28*C
−Endo 3.23±0.51# 3.37±0.50 2.28±0.28# 4.96±0.92*P 5.66±0.88 *T,C,P 5.69±0.65 *T,C,P
DPN 7.64±1.33 6.52±1.54 3.45±0.85 *T 6.33±0.35*P 5.77±0.85 5.95±0.85
−Endo 1.76±0.00# 4.19±1.54 4.73±2.97 7.14±1.34 *T 5.68±0.72 *T,C 7.01±0.89*t
G1 7.71±1.89 7.15±1.30 4.75±1.55 4.64±0.99 8.26±1.16 5.35±0.82
−Endo 1.76±0.00# 3.53±1.03 2.63±0.73 7.56±1.13 *T,C,P 7.30±0.40 *T,C,P 6.23±0.34 *T,P

pEC50 (−log M) Relaxation
of KCl Contraction
E2 2.54±0.40 3.57±0.52 3.18±0.49 3.52±0.78 4.11±0.84 4.07±0.56
PPT 3.09±0.66 4.96±0.66 2.50±0.50*C 5.36±0.84 *T,P 8.90±0.62 *T,C,P,A 6.68±1.07 *T,P
DPN 1.76±0.00 4.01±0.73 *T 1.76±0.00*C 5.67±1.16 *T,P 5.97±0.98 *T,P 5.09±0.90*t,p
G1 3.50±1.74 3.91±0.89 1.76±0.00 6.56±1.22*P 8.64±0.75*C,P 6.27±1.15*P

Data represent means±SEM, n= 8 to 10.

*

Significantly different (p<0.05) from corresponding measurement in thoracic aorta [T], carotid [C], pulmonary [P], abdominal aorta [A], mesenteric [M] and renal artery [R].

#

Measurements in endothelium-denuded vessels (−Endo) are significantly different (p<0.05) from corresponding measurements in intact vessels.